What is NeoSleep?
NeoSleep operates as an AASM-accredited sleep medicine practice, distinguishing itself through a comprehensive, integrative approach to diagnosing and treating sleep disorders in both pediatric and adult populations. Under the clinical leadership of Dr. Chimoskey, the practice combines over two decades of medical expertise with a patient-centered philosophy. By integrating advanced telemedicine capabilities with traditional clinical diagnostics, NeoSleep effectively bridges the gap between high-quality therapeutic care and modern patient convenience, ensuring that personalized treatment plans remain accessible and effective.
How much funding has NeoSleep raised?
NeoSleep has raised a total of $20K across 1 funding round:
Debt
$20K
Debt (2021): $20K with participation from PPP
Key Investors in NeoSleep
PPP
Public-Private Partnership
What's next for NeoSleep?
With the infusion of this recent investment, NeoSleep is strategically positioned to scale its clinical infrastructure and broaden its reach in the competitive healthcare market. The firm is expected to prioritize the expansion of its digital health offerings, further refining its telemedicine platform to accommodate a growing patient base. As the company transitions through this significant growth phase, the focus will likely remain on maintaining rigorous AASM standards while exploring new diagnostic technologies that improve patient outcomes and operational efficiency in the evolving sleep health industry.
See full NeoSleep company page
